1Coiffier B, Feugier P, Mounier N, et al. Long-term results of the GELA study comparing R-CHOP and CHOP chemotherapy in older patients with diffuse large B-cell lymphoma show good survival in poor-risk patients[J]. J Clin Oncol, 2007, 25(18):8009.
2Feugier P, Van Hoof A, Sebban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte[J]. J Clin Oneol, 2005, 23(18):4117-4126.
3Pfreundschuh M, Tru'mper L, Kloess M, et al. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL[J]. Blood, 2004, 104:634-641.
4Bertoni F, Zucca E, Cotter FE. Molecular basis of mantle cell lymphoma[J]. Br J Haematol, 2004, 124:130- 140.
5Romaguera JE, Fayad L, Rodriguez MA, et al. Rituximab plus hyperCVAD (R-HCVAD) alternating with rituximab plus high-dose methotrexate-eytarabine (RM/A) : prolonged follow-up comfirms high rates of failure-free survival (FFS) and overall survival (OS) [J]. Blood, 2004:104 (128).
6Morgner A. Miehlke S, Fischbach W, et al. Complete remission of primary high-grade B cell gastric lymphoma after cure of Helicobacter pylori infection[J]. J Clin Oncol, 2001, 19:2041-2048.
